New drug for Alzheimer’s disease shows promise in phase 3 trial
Sep 28, 2022
Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer’s-associated amyloid plaques in the brain.
Increasing workforce, providing training top Alzheimer’s task force goals
By
Kimberly Bonvissuto
Jan 31, 2023
Increasing the workforce and providing dementia competency training are among the recommendations from a Missouri task force on Alzheimer’s care.
Alzheimer’s Association’s new ‘Superhub’ can help providers launch dementia care training programs
By
Kimberly Bonvissuto
May 23, 2024
Senior living and other long-term care providers looking to launch their own dementia care training programs now can turn to the Alzheimer’s Association, which was just named the world’s first Project...
Bipartisan efforts would accelerate dementia care workforce preparedness, access to care
By
Kimberly Bonvissuto
Mar 26, 2024
A bipartisan bill that has been introduced would better prepare primary care providers to diagnose disease and care for people living with dementia, according to the Alzheimer’s Association.
State updates plan to improve access to dementia care
By
Kimberly Bonvissuto
Feb 21, 2024
Rhode Island recently unveiled a five-year update to its state plan to improve access to dementia care as well as improve quality of life for those living with Alzheimer’s disease or another form of...
Bipartisan group pushes CMS to expand coverage for Alzheimer’s treatments
By
Kimberly Bonvissuto
Feb 21, 2023
Access to federally approved monoclonal antibody and other disease-modifying therapies for Alzheimer’s disease will be “extremely limited” unless the Centers for Medicare & Medicaid Services reconsiders...
$14.6 million study, a first, aims to combat dementia in Native, Pacific Islander communities
By
Kimberly Bonvissuto
May 24, 2023
A first-ever study will adapt Alzheimer’s tests for Indigenous communities to expand treatment and research options for dementia in those populations.
‘Substantial’ decline in dementia rates due in part to higher education levels: study
By
Kimberly Bonvissuto
Nov 08, 2022
The prevalence of dementia in older adults in the United States declined 30% between 2000 and 2016, possibly due to rising education levels, a reduction in smoking and better treatment of cardiovascular...
2023 proved to be a ‘landmark’ year in progress toward treatment of Alzheimer’s disease
By
Kimberly Bonvissuto
Dec 15, 2023
The 2023 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday, highlighting “landmark” progress made over the past year in understanding...
$4 billion increase in Alzheimer’s funding needed to prevent ‘catastrophe,’ coalition with provider...
By
Kimberly Bonvissuto
Jul 11, 2023
Funding the national response to Alzheimer’s and related dementias is a “national priority, economic and budgetary necessity, health and moral imperative,” according to a coalition of 360 organizations...